Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
HotHouse Therapeutics
United Kingdom
- Norwich, Norfolk
- 03/12/2025
- Pre-Seed
- $3,835,279
HotHouse Therapeutics is rewriting the future of drug discovery with BotanAI and BotanBio - our AI and plant bioengineering platforms that design and make molecules labs can’t reach.
By transforming plants into sustainable biofactories, we unlock vast new chemical space, creating next-generation vaccine adjuvants and breakthrough therapeutics in days, not years.
The urgency is clear: 62% of today’s medicines are natural or nature-inspired, yet conventional chemistry is slow, expensive, and environmentally harmful. As a sustainable biotech, our approach is different. Because our medicines grow in plants, they scale through vertical farming, are carbon-positive by design, and avoid destructive extraction.
With deep expertise in plant science, chemistry, and AI, we’re building not just a pipeline, but a platform - delivering next-generation medicines that are greener, faster, and smarter.
- Industry Biotechnology Research
- Website https://hothousetx.com/
- LinkedIn https://www.linkedin.com/company/hothousetx/
Related People
David SheppardFounder
United Kingdom -
Cambridge, England
Biotech entrepreneur, innovator, leader and consultant. Pioneer of Targeted Protein Stabilisation, Founder of EntactBio and Board member of RevoNA Bio. Experienced, enthusiastic and entrepreneurial pharmaceuticals professional, a proven track record of scientific excellence and a passion for disruptive innovation through new technology platforms and start-ups.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)